Vyvanse and Suboxone drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Vyvanse and Suboxone together. This review analyzes the effectiveness and drug interactions between Vyvanse and Suboxone. It is created by eHealthMe based on reports of 49 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Vyvanse and Suboxone, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Vyvanse and Suboxone

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 13,789 users)

Suboxone

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. (latest outcomes from Suboxone 15,972 users)

On Feb, 02, 2017

49 people who take Vyvanse, Suboxone are studied.


Number of reports submitted per year:

Vyvanse and Suboxone drug interactions.

Most common drug interactions over time *:

< 1 month:
  • adverse drug reaction
  • hypertension
  • nausea
  • bronchitis
  • chills
  • drug ineffective
  • fatigue
  • hot flush
  • hyperhidrosis
  • hypoacusis
1 - 6 months:
  • dizziness
  • drug withdrawal syndrome neonatal
  • drug ineffective
  • fatigue
  • foetal exposure during pregnancy
  • headache
  • hypoxia
  • influenza like illness
  • irritability
  • lacrimation increased
6 - 12 months:
  • breech presentation
  • drug withdrawal syndrome neonatal
  • foetal distress syndrome
  • foetal exposure during pregnancy
  • jaundice neonatal
  • premature baby
1 - 2 years:
  • chills
  • gastrooesophageal reflux disease
  • hiatus hernia
  • impaired gastric emptying
  • therapeutic response unexpected
  • weight increased
  • abnormal sleep-related event
  • abortion spontaneous
  • bronchitis
  • chest pain
2 - 5 years:
  • abdominal pain upper
  • diarrhoea
  • dizziness
  • drug ineffective
  • drug withdrawal syndrome
  • fatigue
  • feeling of body temperature change
  • formication
  • headache
  • hypoxia
5 - 10 years:
  • gastrooesophageal reflux disease
  • hiatus hernia
  • impaired gastric emptying
  • pre-existing condition improved
  • therapeutic response unexpected
  • abnormal sleep-related event
  • chest pain
  • decreased eye contact
  • hypersomnia
  • impulsive behaviour
not specified:
  • somnolence
  • drug ineffective
  • constipation
  • dizziness
  • drug withdrawal syndrome neonatal
  • feeling abnormal
  • nausea
  • weight increased
  • drug effect decreased
  • foetal exposure during pregnancy

Most common drug interactions by gender *:

female:
  • feeling abnormal
  • drug effect decreased
  • drug ineffective
  • hot flush
  • nausea
  • obsessive-compulsive disorder
  • weight increased
  • drug diversion
  • dyspnoea
  • bronchitis
male:
  • drug withdrawal syndrome neonatal
  • foetal exposure during pregnancy
  • fatigue
  • somnolence
  • jaundice neonatal
  • premature baby
  • drug ineffective
  • nausea
  • aggression
  • breech presentation

Most common drug interactions by age *:

0-1:
  • drug withdrawal syndrome neonatal
  • foetal exposure during pregnancy
  • jaundice neonatal
  • premature baby
  • maternal drugs affecting foetus
  • breech presentation
  • foetal distress syndrome
20-29:
  • aggression
  • drug intolerance
  • impaired driving ability
  • intentional overdose
  • mania
  • drug ineffective
  • gastrooesophageal reflux disease
  • hiatus hernia
  • impaired gastric emptying
  • abdominal pain upper
30-39:
  • hot flush
  • nausea
  • bronchitis
  • chills
  • hyperhidrosis
  • hypoacusis
  • neuralgia
  • pain
  • polychondritis
  • therapeutic response unexpected
40-49:
  • depression
  • drug effect decreased
  • drug effect increased
  • insomnia
  • irritability
  • lethargy
  • logorrhoea
  • obsessive-compulsive disorder
  • depressed mood
  • activities of daily living impaired
50-59:
  • asthenia
  • asthma
  • constipation
  • disturbance in attention
  • dyspnoea
  • feeling abnormal
  • hallucination
  • oedema peripheral
  • periorbital oedema
  • somnolence
60+:
  • abdominal pain
  • constipation
  • myocardial infarction
  • urinary retention
  • hyperlipidaemia
  • hypertensive heart disease
  • nausea
  • unresponsive to stimuli

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vyvanse and Suboxone?

Interactions between Vyvanse and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Suboxone and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) is often used to treat drug dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Can you answer these questions?

More questions for: Vyvanse, Suboxone

You may be interested in these reviews

More reviews for: Vyvanse, Suboxone